In a research report released this morning, Canaccord Genuity analyst Mark Massaro initiated coverage on shares of Illumina, Inc (NASDAQ:ILMN) with a Buy rating …
Illumina, Inc. (NASDAQ:ILMN) announced the launch of Illumina SeqLab, an integrated solution for customers with HiSeq X™ Systems to enable large-scale human whole-genome sequencing …
Illumina, Inc. (NASDAQ:ILMN) announced that a preliminary study retrospectively correlated 10 cases of occult maternal cancer among pregnant women receiving an “aneuploidy detected” or …
Biomed Realty Trust Inc (NYSE:BMR) announced that Illumina, Inc. (NASDAQ:ILMN), a world leader in genomics focused on improving human health by unlocking the …
Illumina, Inc. (NASDAQ:ILMN) announced that the company has filed a new patent infringement suit againstAriosa Diagnostics, Inc.
As previously described here, the Sequenom, Inc. (NASDAQ:SQNM) IP Pool agreement with Illumina, Inc.
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the first quarter of fiscal year 2015.
After an incredible run, investors are finally seeing some pain in the biotech and broader health care sector. Major biotechnology indexes were off …
